Patient Perspectives on Preimplantation Genetic Diagnosis by Melnick, Samantha
Printing:
This poster is 48” wide by 36” high. 
It’s designed to be printed on a 
large
Customizing the Content:
The placeholders in this 
formatted for you. 
placeholders to add text, or click 
an icon to add a table, chart, 
SmartArt graphic, picture or 
multimedia file.
T
from text, just click the Bullets 
button on the Home tab.
If you need more placeholders for 
titles, 
make a copy of what you need and 
drag it into place. PowerPoint’s 
Smart Guides will help you align it 
with everything else.
Want to use your own pictures 
instead of ours? No problem! Just 
right
Change Picture. Maintain the 
proportion of pictures as you resize 
by dragging a corner.
0 5 10 15 20 25





Perspectives of Preimplantation Genetic Diagnosis (PGD) Patients: Comparing Attitudes 
of Carriers with a Previously Affected Pregnancy to Patients Identified as Carriers 
through Expanded Carrier Screening
Samantha Melnick, MS1, Jill Fischer, MS, CGC1 , and Amy Jordan, MS, CGC2
1Long Island University – Post, Brookville, NY    2Reprogenetics, LLC, Livingston, NJ
BACKGROUND
• Preimplantation genetic diagnosis (PGD) is available to couples at risk for 
transmitting inherited genetic disorders to offspring. Utilized with in-vitro
fertilization (IVF), PGD affords couples in which both partners are carriers 
for the same autosomal recessive condition the chance to have embryos 
tested in the preimplantation stage.  Subsequently, unaffected embryos are 
selected for transfer with the intent of establishing a healthy pregnancy.
• Couples in which both partners are carriers for the same autosomal 
recessive disorder have a 25% chance to have an affected child. Prior to 
the advent of PGD, the only option available to carriers of a single gene 
disorder who wished to have their own biological children was to perform 
diagnostic testing during pregnancy, with the choice of termination of an 
affected pregnancy. PGD testing has enabled carrier couples to make 
decisions in the preconception stage.
• As carriers are typically asymptomatic, PGD for autosomal recessive 
conditions presents some unique considerations, namely in identification of 
carrier status of both partners. Some couples learn that both partners are 
carriers for a genetic disorder after having an affected pregnancy or child. 
Other patients, particularly in recent years, seek IVF with PGD only after 
the administration of carrier screening, a test for both partners that will 
indicate carrier status for a various genetic syndromes. 
• In recent years, as genetic testing capabilities and affordability have 
improved, expanded carrier screening (ECS) has become more widely 
available to preconception and prenatal patients. Many commercial 
companies now offer expanded panel tests for general population carrier 
screening, designed to detect carrier status for hundreds of autosomal 
recessive and X-linked recessive conditions. 
• This study examines the perspectives of patients seeking PGD for 
autosomal recessive conditions, with the aim of defining factors that may 
differ between patients with a previously affected pregnancy or child and 
patients identified as carriers through ECS
OBJECTIVES
• Compare and contrast the attitudes, opinions, and beliefs of two groups of 
PGD patients: patients who learned of carrier status after a previously 
affected pregnancy or child versus patients who learned of carrier status 
after administration of ECS
• Explore perceived benefits and limitations of PGD
• Assess how patients experienced genetic counseling for PGD
RESULTS DISCUSSION
CONCLUSIONS
• The subjects in this study had a range of personal and reproductive 
histories. While individual experiences shaped some patient attitudes about 
the PGD process, overall, subjects in both groups expressed common 
themes surrounding their experience with PGD 
• Having an affected pregnancy or child is a traumatic event for parents, who 
view PGD as a means to prevent additional suffering and pain
• The length of time required for the PGD process can be perceived as a 
drawback by patients. In this study, the length of the process was 
perceived as more disadvantageous than the cost of PGD.
• Genetic counseling that provides opportunities for patients to reflect on 
their experiences and ask questions, as well as post-test follow-up, is 
viewed as beneficial by PGD patients
METHODS
• Patients were recruited from Reprogenetics, a PGD reference laboratory in 
Livingston, New Jersey. Patients who had undergone PGD for an 
autosomal recessive condition within the previous 15 months were invited 
to participate in a 15-minute phone interview about their respective PGD 
experiences. 
• The phone survey consisted of open-ended questions about carrier status, 
prior experience with the genetic condition, perceived benefits and 
limitations of PGD, and experience with genetic counseling 
• Interviews were recorded and transcribed. Thematic coding was used to 
identify significant topics, followed by a comparison of theme distribution 
across subject groups. Subcategories were created within each code to 
explore similarities and differences between patient groups.  
LIMITATIONS
Demographics & Pregnancy History
Thematic Analysis
• This study had a small sample size (n=28) due to a low response rate 
(25.2%), a common limitation of telephone-based surveys 
• The diversity of genetic conditions and specific subject experiences limit 
the ability to draw generalized conclusions for all PGD patients
• No evaluation was performed to examine PGD treatment success in 
association with perceived benefits or satisfaction with genetic counseling
This study of 28 individuals who had undergone PGD provides insight into the 
perceived benefits and challenges of the PGD process. Four recurrent themes 
were identified: drive to reduce anxiety, trauma, the urgency of the PGD 
process, and patients acting as self-advocates. With the exception of trauma, 
all themes came up in conversation with subjects in both groups. The results 
suggest that while PGD patients with previous pregnancy or child affected by 
a genetic disorder must deal with an additional emotional component during 
treatment, patients in both groups have similar concerns and reactions during 
the PGD process. 
Patients with affected pregnancies or children often discussed the 
traumatizing nature of their previous experiences. For these individuals, the 
choice to pursue PGD was viewed as a protective mechanism, essential to 
avoiding future psychological harm. In addition, patients with affected 
pregnancies sought PGD over a shorter time frame than do patients identified 
as carriers on ECS, which is likely a reaction to the substantial emotional 
burden of prior events.
Previous studies have focused on cost as a deterrent to seeking PGD. While 
the financial cost of PGD was considered an obstacle to treatment by 
subjects, length of time for completing the PGD testing process was cited by 
more subjects as a drawback. 
Twenty-five (89%) patients were satisfied with genetic counseling, while three 
patients desired additional post-test follow-up.
Perspectives on Benefits of PGD
 
 
Group 1: Carrier 
Screening (n=14) 
n (%) 
Group 2: Prior 
Affected (n=14)  
n (%) 
Demographics 
Sex of subjects     Female (100%)     Female (100%) 
Mean age of subjects 34.6 years 33.2 years 
Pregnancy history*                                    
Nulligravida  10 (72%) 0 (0%) 
Spontaneous abortion 2 (14%) 3 (21%) 
Stillbirth 0 (0%) 0 (0%) 
Termination of pregnancy 0 (0%) 4 (29%) 
Child(ren) 2 (14%) 9 (64%) 
Status of child(ren)* 
Affected, living 0 (0%) 8 (57%) 
Affected, deceased 0 (0%) 2 (14%) 
Unaffected, living 2 (14%) 2 (14%) 
Unaffected, deceased 0 (0%) 0 (0%) 
*multiple responses from one individual 
Perspectives on Drawbacks of PGD
*Some patients listed 
more than one drawback
*Some patients listed 
more than one benefit
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